CRISPR Therapeutics AG

NasdaqGM:CRSP

Location

Market Cap

USD 5.10 B

Share Price

USD 56.80

Avg Daily Volume

2,587,653

Change (1 day)

-3.73%

Change (1 year)

-0.02%

Change (YTD)

44.31%

CRISPR Therapeutics AG Income Statement 2015 - 2025

This table shows the Income Statement for CRISPR Therapeutics AG going from 2015 until 2025. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.

Income Statement

Annual data in millions of USD, except per share data Trend